Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
389
datasets available to search
ShareScore release 0.9.0
Dataset results
389 results for “Acute myeloid leukemia (AML)”
LENA-LMA-5:Lenalidomide in Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01198054. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open, Single Center, Randomized Controlled Clinical Study of UCB (Cord Blood) in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05577611. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Development and Application of a Novel Digital Array PCR for Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT04920188. IPD Sharing: NO. Countries: 1. Publications: 0.
Nonmyeloablative Preparative Regimen Using Mylotarg for Patients With High Risk Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myeloid Leukemia (CML) and Myelodysplastic Syndr
ClinicalTrials.gov study NCT00038805. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Results From a French Temporary Utilization Authorization of First-line Acute Myeloid Leukemia (AML) Patients Ineligible for Intensive Chemotherapy (IC), Treated With Venetoclax Azacitidine
ClinicalTrials.gov study NCT06263387. IPD Sharing: NO. Countries: 1. Publications: 0.
Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality
ClinicalTrials.gov study NCT06370000. IPD Sharing: NO. Countries: 1. Publications: 0.
CER-1236 in Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT06834282. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy in Switzerland and Austria Receiving Oral Venetoclax Tablets
ClinicalTrials.gov study NCT05215639. IPD Sharing: UNDECIDED. Countries: 2. Publications: 0.
A Study of Oral Venetoclax Tablet in Combination With Subcutaneous Low-Dose Cytarabine (LDAC) Injection to Assess Adverse Events in Adult Japanese Participants With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT04509622. IPD Sharing: YES. Countries: 1. Publications: 0.
Liposome-encapsulated Daunorubicin-Cytarabine and Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT03672539. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dexamethasone Added to Intensive Chemotherapy in Older Patients with Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03609060. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Risk Adapted Treatment for Primary Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01723657. IPD Sharing: Not stated. Countries: 1. Publications: 0.
VCA Regimen Followed by D-MAG Regimen on the Treatment of Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05603884. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 1 Study With LYT-200 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML), or With Relapsed/Refractory, High-risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT05829226. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Creation of a Biocollection of Patients with Acute Myeloid Leukemia (AML) or Lymphoid Leukemia (ALL) or High-risk Myelodysplastic Syndrome (MDS) Monitored At the Nantes University Hospital
ClinicalTrials.gov study NCT06681363. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study to Find a Safe and Effective Dose of SKI-G-801 in the Treatment of Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03564288. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase Ib Study of CT053PTSA in Relapsed / Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03125876. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Receiving Oral Venetoclax Tablets in Combination With Subcutaneously (SC) or Intravenously (IV) Inject
ClinicalTrials.gov study NCT05587049. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study to Assess Safety and Tolerability of CC-486 (ONUREG®, Oral Azacitidine) in Combination Therapy in Participants With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT04887857. IPD Sharing: YES. Countries: 2. Publications: 0.
HDM201 in Combination With MBG453 or Venetoclax in Patients With Acute Myeloid Leukemia (AML) or High-risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT03940352. IPD Sharing: NO. Countries: 7. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.